Sökning: WFRF:(Lindblad F.) > Incidence of SARS-C...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06319naa a2201249 4500 | |
001 | oai:gup.ub.gu.se/308047 | |
003 | SwePub | |
008 | 240528s2021 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:147418919 | |
024 | 7 | a https://gup.ub.gu.se/publication/3080472 URI |
024 | 7 | a https://doi.org/10.1016/j.jcf.2021.03.0172 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1474189192 URI |
040 | a (SwePub)gud (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Naehrlich, L.4 aut |
245 | 1 0 | a Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020 |
264 | 1 | b Elsevier BV,c 2021 |
520 | a Background: Viral infections can cause significant morbidity in cystic fibrosis (CF). The current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could therefore have a serious impact on the health of people with CF (pwCF). Methods: We used the 38-country European Cystic Fibrosis Society Patient Registry (ECFSPR) to collect case data about pwCF and SARS-CoV-2 infection. Results: Up to 30 June 2020, 16 countries reported 130 SARS-CoV-2 cases in people with CF, yielding an incidence of 2.70/10 0 0 pwCF. Incidence was higher in lung-transplanted patients (n = 23) versus non transplanted patients (n = 107) (8.43 versus 2.36 cases/10 0 0). Incidence was higher in pwCF versus the age-matched general population in the age groups < 15, 15-24, and 25-49 years (p < 0.001), with similar trends for pwCF with and without lung transplant. Compared to the general population, pwCF (regardless of transplantation status) had significantly higher rates of admission to hospital for all age groups with available data, and higher rates of intensive care, although not statistically significant. Most pwCF recovered (96.2%), however 5 died, of whom 3 were lung transplant recipients. The case fatality rate for pwCF (3.85%, 95% CI: 1.26-8.75) was non-significantly lower than that of the general population (7.46%; p = 0.133). Conclusions: SARS-CoV-2 infection can result in severe illness and death for pwCF, even for younger patients and especially for lung transplant recipients. PwCF should continue to shield from infection and should be prioritized for vaccination. (c) 2021 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng |
653 | a Cystic fibrosis | |
653 | a Covid-19 | |
653 | a SARS-CoV-2 | |
653 | a Europe | |
653 | a Incidence | |
653 | a Epidemiology | |
653 | a impact | |
653 | a Respiratory System | |
700 | 1 | a Orenti, A.4 aut |
700 | 1 | a Dunlevy, F.4 aut |
700 | 1 | a Kasmi, I.4 aut |
700 | 1 | a Harutyunyan, S.4 aut |
700 | 1 | a Pfleger, A.4 aut |
700 | 1 | a Keegan, S.4 aut |
700 | 1 | a Daneau, G.4 aut |
700 | 1 | a Petrova, G.4 aut |
700 | 1 | a Tjesic-Drinkovic, D.4 aut |
700 | 1 | a Yiallouros, P.4 aut |
700 | 1 | a Bilkova, A.4 aut |
700 | 1 | a Olesen, H. V.4 aut |
700 | 1 | a Burgel, P. R.4 aut |
700 | 1 | a Parulava, T.4 aut |
700 | 1 | a Diamantea, F.4 aut |
700 | 1 | a Parniczky, A.4 aut |
700 | 1 | a McKone, E. F.4 aut |
700 | 1 | a Mei-Zahav, M.4 aut |
700 | 1 | a Salvatore, M.4 aut |
700 | 1 | a Colombo, C.4 aut |
700 | 1 | a Aleksejeva, E.4 aut |
700 | 1 | a Malakauskas, K.4 aut |
700 | 1 | a Schlesser, M.4 aut |
700 | 1 | a Fustik, S.4 aut |
700 | 1 | a Turcu, O.4 aut |
700 | 1 | a Zomer-van Ommen, D.4 aut |
700 | 1 | a Wathne, A. S.4 aut |
700 | 1 | a Wozniacki, L.4 aut |
700 | 1 | a Pereira, L.4 aut |
700 | 1 | a Pop, L.4 aut |
700 | 1 | a Kashirskaya, N.4 aut |
700 | 1 | a Rodic, M.4 aut |
700 | 1 | a Kayserova, H.4 aut |
700 | 1 | a Krivecs, U.4 aut |
700 | 1 | a Mondejar-Lopez, P.4 aut |
700 | 1 | a de Monsterol, I.4 aut |
700 | 1 | a Dogru, D.4 aut |
700 | 1 | a Makukh, H.4 aut |
700 | 1 | a Cosgriff, R.4 aut |
700 | 1 | a van Koningsbruggen-Rietschel, S.4 aut |
700 | 1 | a Jung, A. D.4 aut |
700 | 1 | a Bobrovnichy, V.4 aut |
700 | 1 | a Bambir, I.4 aut |
700 | 1 | a Vukic, A. D.4 aut |
700 | 1 | a Drevinek, P.4 aut |
700 | 1 | a Macek, M.4 aut |
700 | 1 | a Corvol, H.4 aut |
700 | 1 | a Lemonnier-Videau, L.4 aut |
700 | 1 | a Hatziagorou, E.4 aut |
700 | 1 | a Fletcher, G.4 aut |
700 | 1 | a Padoan, R.4 aut |
700 | 1 | a Gulmans, V.4 aut |
700 | 1 | a Bakkeheim, E.4 aut |
700 | 1 | a Kondratyeva, E.4 aut |
700 | 1 | a Amelina, E.4 aut |
700 | 1 | a Zhekaite, E.4 aut |
700 | 1 | a Simonova, O.4 aut |
700 | 1 | a Pastor-Vivero, M. D.4 aut |
700 | 1 | a Lindblad, Anders,d 1955u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics4 aut0 (Swepub:gu)xlinaq |
700 | 1 | a Gokdemir, Y.4 aut |
700 | 1 | a Pekcan, S.4 aut |
700 | 1 | a Brownlee, K.4 aut |
700 | 1 | a McClenaghan, E.4 aut |
700 | 1 | a Carr, S.4 aut |
700 | 1 | a Lammertyn, E.4 aut |
700 | 1 | a Zolin, A.4 aut |
700 | 1 | a Fox, A.4 aut |
700 | 1 | a Krasnyk, M.4 aut |
700 | 1 | a Van Rens, J.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för pediatrik4 org |
773 | 0 | t Journal of Cystic Fibrosisd : Elsevier BVg 20:4, s. 566-577q 20:4<566-577x 1569-1993 |
773 | 0 | t Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Societyd : Elsevier BVg 20:4, s. 566-577q 20:4<566-577x 1873-5010 |
856 | 4 | u http://www.cysticfibrosisjournal.com/article/S1569199321000990/pdf |
856 | 4 8 | u https://gup.ub.gu.se/publication/308047 |
856 | 4 8 | u https://doi.org/10.1016/j.jcf.2021.03.017 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:147418919 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.